Limited utility of the HScore in detecting secondary haemophagocytic lymphohistiocytosis in COVID-19: response.
作者信息
Wood Henry, Kulasekararaj Austin G
机构信息
Department of Haematological Medicine, King's College Hospital-NHS Foundation Trust, London, UK.
King's College London, London, UK.
出版信息
Br J Haematol. 2021 Aug;194(4):688-689. doi: 10.1111/bjh.17535. Epub 2021 May 16.
Abstract
摘要
相似文献
1
Limited utility of the HScore in detecting secondary haemophagocytic lymphohistiocytosis in COVID-19: response.HScore在检测COVID-19继发噬血细胞性淋巴组织细胞增生症中的应用有限：回应
Br J Haematol. 2021 Aug;194(4):688-689. doi: 10.1111/bjh.17535. Epub 2021 May 16.
2
Limited utility of the HScore in detecting secondary haemophagocytic lymphohistiocytosis in COVID-19.HScore在检测COVID-19继发性噬血细胞性淋巴组织细胞增生症中的应用有限。
Br J Haematol. 2021 Aug;194(4):686-688. doi: 10.1111/bjh.17533. Epub 2021 May 16.
3
[Secondary hemophagocytic lymphohistiocytosis and cytokine release syndrome in COVID-19, the same or different entities?].[新型冠状病毒肺炎中的继发性噬血细胞性淋巴组织细胞增生症和细胞因子释放综合征，是同一实体还是不同实体？]
Rev Chilena Infectol. 2021 Apr;38(2):271-278. doi: 10.4067/S0716-10182021000200271.
4
Hemophagocytic lymphohistiocytosis: a review inspired by the COVID-19 pandemic.噬血细胞性淋巴组织细胞增生症：COVID-19 大流行引发的综述。
Rheumatol Int. 2021 Jan;41(1):7-18. doi: 10.1007/s00296-020-04636-y. Epub 2020 Jun 25.
5
Assessment of the Hemophagocytic Lymphohistiocytosis HScore in Patients With Coronavirus Disease 2019.评估 COVID-19 患者的噬血细胞性淋巴组织细胞增生症 H 评分。
Clin Infect Dis. 2021 Nov 2;73(9):e3110-e3112. doi: 10.1093/cid/ciaa1463.
6
Secondary haemophagocytic lymphohistiocytosis in hospitalised COVID-19 patients as indicated by a modified HScore is infrequent and high scores do not associate with increased mortality.住院 COVID-19 患者中由改良 H 评分提示的二级噬血细胞性淋巴组织细胞增生症不常见，高分与死亡率增加无关。
Clin Med (Lond). 2021 Sep;21(5):e543-e547. doi: 10.7861/clinmed.2021-0053. Epub 2021 Aug 13.
7
Risk factors for secondary hemophagocytic lymphohistiocytosis in severe coronavirus disease 2019 adult patients.严重 2019 冠状病毒病成年患者发生继发性噬血细胞性淋巴组织细胞增生症的危险因素。
BMC Infect Dis. 2021 Apr 29;21(1):398. doi: 10.1186/s12879-021-06094-8.
8
Hemophagocytic syndrome secondary to SARS-Cov-2 infection: a case report.继发于 SARS-CoV-2 感染的噬血细胞综合征：一例报告。
BMC Infect Dis. 2021 Aug 13;21(1):811. doi: 10.1186/s12879-021-06532-7.
9
Severe COVID-19-associated hyperinflammatory syndrome versus classic hemophagocytic lymphohistiocytosis: similarities, differences, and the way forward.严重 COVID-19 相关的过度炎症综合征与经典噬血细胞性淋巴组织细胞增生症：相似之处、不同之处及未来方向。
J Investig Med. 2023 Mar;71(3):244-253. doi: 10.1177/10815589221140596.
10
Hemophagocytic lymphohistiocytosis in COVID-19: Case reports of a stepwise approach.COVID-19 相关噬血细胞性淋巴组织细胞增生症：逐步治疗方法的病例报告。
Medicine (Baltimore). 2021 Mar 26;100(12):e25170. doi: 10.1097/MD.0000000000025170.
本文引用的文献
1
Secondary HLH is uncommon in severe COVID-19.继发性噬血细胞性淋巴组织细胞增生症（HLH）在重症新型冠状病毒肺炎（COVID-19）中并不常见。
Br J Haematol. 2020 Sep;190(5):e283-e285. doi: 10.1111/bjh.16934. Epub 2020 Aug 10.
2
COVID-19: consider cytokine storm syndromes and immunosuppression.2019冠状病毒病：考虑细胞因子风暴综合征和免疫抑制。
Lancet. 2020 Mar 28;395(10229):1033-1034. doi: 10.1016/S0140-6736(20)30628-0. Epub 2020 Mar 16.
Zotero 插件